Ikarian Capital’s BiomX PHGE Stock Holding History

Ikarian Capital’s Portfolio PHGE Stock Details PHGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$73.1K	Hold	19,473	–	–	0.01%	152
2025 Q4	$36.4K	Sell	19,473 -1,210	-6%	-$8.14K	﹤0.01%	169
2025 Q3	$206K	Sell	20,683 -26,316	-56%	-$243K	0.02%	152
2025 Q2	$402K	Hold	46,999	–	–	0.08%	96
2025 Q1	$496K	Hold	46,999	–	–	0.06%	116
2024 Q4	$652K	Sell	46,999 -1	-0%	-$14	0.09%	122
2024 Q3	$911K	Buy	+47,000	New	+$1.7M	0.13%	98

Other funds holding PHGE

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Ikarian Capital's PHGE Position: Q1 2026 in Review

Ikarian Capital held its BiomX (PHGE) position steady in Q1 2026 at 19,473 shares worth $73.1K. The position accounts for 0.01% of the portfolio, ranked #152.

Ikarian Capital first reported a position in PHGE in Q3 2024 and has held it in 7 quarters since. The position peaked at $911K in Q3 2024. 13 funds tracked by Wall St. Rank hold PHGE as of Q1 2026.

Ikarian Capital held 19,473 shares of BiomX worth $73.1K as of Q1 2026.
Ikarian Capital left its BiomX share count unchanged in Q1 2026.
BiomX made up 0.01% of Ikarian Capital's portfolio in Q1 2026, its #152 holding.
Ikarian Capital first reported a position in BiomX in Q3 2024 and has held it in 7 quarters since.
Ikarian Capital's BiomX position peaked at $911K in Q3 2024.
13 funds tracked by Wall St. Rank held BiomX as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.